Related Experiment Videos
Studies of the RB1 gene and the p53 gene in human osteosarcomas
R B Scholz1, H Kabisch, B Weber
1Department of Hematology and Oncology, Children's University Hospital Hamburg, Germany.
Abstract:
We analyzed 14 native osteosarcoma tissue samples for alterations of the tumor suppressor genes RB1 and p53 on the DNA level, and as far as possible, the RNA level. Southern blot analyses concerning both tumor suppressor genes were carried out in all osteosarcomas. In two cases we could demonstrate a deletion within the RB1 gene. DNA analysis of a third osteosarcoma patient revealed a rearrangement of the p53 gene. We had the opportunity of performing corresponding northern analyses in eight native osteosarcoma specimens. The RB1 gene expression was significantly decreased or completely absent in six tumor samples. In two of these tissue probes the expression of both tumor suppressor genes was missing. We determined coexistence of decreased expression of both tumor suppressor genes in one additional case. In summary, 7/14 or 6/8 cases of osteosarcomas (including only those cases which allowed both analyses) showed RB1 gene alteration. In 3/14 or 3/8 osteosarcomas we could determine p53 gene abnormalities. This may indicate that either loss of p53 function is etiologically important only for the development of some osteosarcomas, or a major part of p53 gene mutations are subtle ones and their detection requires more sophisticated techniques, which are currently under development.
Insights
Alterations in the RB1 and p53 tumor suppressor genes were found in osteosarcoma tissues. These gene changes may play a role in the development of this bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma is a primary bone malignancy.
- Tumor suppressor genes like RB1 and p53 are critical in preventing cancer development.
- Alterations in these genes are implicated in various cancers.
Purpose of the Study:
- To investigate alterations in the RB1 and p53 tumor suppressor genes in osteosarcoma.
- To analyze both DNA and RNA levels for gene abnormalities.
- To correlate gene alterations with osteosarcoma development.
Main Methods:
- Analysis of 14 native osteosarcoma tissue samples.
- Southern blot analysis for DNA-level alterations in RB1 and p53.
- Northern blot analysis for RNA-level gene expression.
- Detection of gene deletions, rearrangements, and expression levels.
Main Results:
- RB1 gene alterations were observed in 7/14 (DNA level) or 6/8 (RNA level) osteosarcoma cases.
- p53 gene abnormalities were detected in 3/14 (DNA level) or 3/8 (RNA level) osteosarcoma cases.
- Decreased or absent RB1 gene expression was noted in six samples; both genes were affected in some cases.
Conclusions:
- RB1 gene alterations are frequent in osteosarcoma.
- p53 gene abnormalities are present in a subset of osteosarcomas.
- The role of p53 in osteosarcoma etiology may be significant but requires further investigation due to potential subtle mutations.